Digital Adopting AI platforms: A structured framework for thoughtful... The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.
R&D 5 strategies for biopharma to optimise patient recruitment i... Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials.
Digital Hybrid and multi-cloud: The next step for biotech to secure ... An unmissable trend for those working in biotech research over the past decade has been the transition to cloud computing.
Digital Clinical trial industry trends in 2023 The clinical trial industry is entering a new era of possibilities in 2023.
Pharma Market Access Pharma manufacturing can digitalise its way round the next c... The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis.
Views & Analysis Keep it simple, scientists: AZ’s productivity push regains 1... AZ time management challenge has saved more than two million hours across the global company.
News Lilly names Thomas Fuchs as its first chief AI officer Eli Lilly has named Thomas Fuchs as its first-ever chief artificial intelligence officer (CAIO), bolstering the digital representation in the group's C-suite.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.